Pharma's BRIC Building

The health care industry's biggest conference just finished up, and the Fool's health care team was keeping close watch. While much of the interest was focused on biotech outfits big and small, the industry's titans -- the big pharmaceutical companies -- made some noise of their own.

Our health care bureau chief, Brenton Flynn, listened in on seven big pharmaceutical companies that made an appearance, and in the following video he dives into one major area of focus for nearly every company: emerging-markets growth.

Over the next two years, Eli Lilly will see nearly $0.40 of every $1.00 in sales exposed to generic competition. How does the company plan to respond to this huge patent cliff? Better yet, what does this mean for investors? In a brand new premium report on Eli Lilly, The Motley Fool's top pharmaceuticals analyst delves into everything investors need to know about the stock today. Simply click here now to claim your copy.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

updated 1 day ago Sponsored by:
	DOW	15,303.10	8.60	0.06%
	S&P 500	1,649.60	-0.91	-0.06%
	NASD	3,459.14	-0.28	-0.01%

NVS	$74.36		+0.54	+0.73%
Novartis		CAPS Rating:

MRK	$47.16		-0.17	-0.36%
Merck & Co., Inc.		CAPS Rating:

LLY	$54.14		-0.60	-1.10%
Eli Lilly & Co.		CAPS Rating:

1

Pharma's BRIC Building

Comments from our Foolish Readers

Be the first one to comment on this article.

Compare Brokers

Report This Comment

Sending report...

Today's Market

Create My Watchlist

You don't seem to be following any stocks yet!

Related Tickers